G S Sachin About This Guide This guide provides supplementary clinical information for the Tedizolid Dose Calculator. It details the standard dosing regimen for tedizolid, explains the clinical parameters used, and outlines key safety considerations based on official prescribing information. The content is intended for healthcare professionals and should not replace clinical judgment. Understanding the Outputs The calculator … Read more
About This Calculator The Delafloxacin Dose Calculator is a clinical support tool designed to help healthcare professionals determine the appropriate dosage of delafloxacin (Baxdela®) for adult patients. It calculates the recommended dose based on the specific indication—Acute Bacterial Skin and Skin Structure Infections (ABSSSI) or Community-Acquired Bacterial Pneumonia (CABP)—and the patient’s renal function, which can … Read more
About This Tool The Succimer (DMSA) Dose Calculator is a clinical support tool designed to assist healthcare professionals in determining appropriate dosing regimens for lead poisoning. Succimer is a chelating agent that binds to heavy metals in the bloodstream, facilitating their excretion from the body. This calculator applies standard, FDA-approved protocols to provide patient-specific dosing … Read more
About This Calculator This Calcium Gluconate Dose Calculator provides initial dosing recommendations for managing two critical conditions: life-threatening hyperkalemia with associated ECG changes and severe toxicity from calcium channel blocker (CCB) or beta-blocker (BB) overdose. The tool calculates appropriate bolus and infusion doses for both adult and pediatric patients based on indication, weight, and other … Read more
About This Tool The Atezolizumab (Tecentriq) Dosing Schedule Calculator is a clinical support tool designed for healthcare professionals to project administration dates for patients receiving atezolizumab. By inputting a start date and selecting a standard regimen, the calculator generates a forward-looking schedule to assist with clinic management, patient communication, and treatment planning. Outputs Explained Upon … Read more
About the Calculator This guide provides supporting information for the Durvalumab (Imfinzi) Dosing Schedule Calculator. The tool is designed to assist healthcare professionals by calculating appropriate doses and generating projected infusion schedules based on indications and regimens approved in the U.S. Prescribing Information. It is intended for educational and informational purposes only and does not … Read more
About This Calculator The Nivolumab (Opdivo) Dosing Schedule Calculator is designed to assist healthcare professionals in mapping out potential treatment timelines for patients. By selecting an approved indication and specific regimen, the tool generates a detailed schedule of administration dates based on the chosen start date and number of cycles. This facilitates planning for both … Read more
About This Calculator The Pembrolizumab (Keytruda) Dosing Schedule Calculator is an informational resource designed for healthcare professionals. It helps visualize and map out potential treatment schedules based on the two approved flat-dose regimens for adult patients. This tool is not a substitute for clinical judgment or official prescribing information. Outputs After entering the required parameters, … Read more
About This Calculator The Oxaliplatin Dose Calculator is designed to assist healthcare professionals in determining the appropriate dose of oxaliplatin for patients undergoing chemotherapy. It streamlines the calculation process by using standard clinical formulas: the Mosteller formula for Body Surface Area (BSA) and the Cockcroft-Gault equation for estimating Creatinine Clearance (CrCl). This tool is intended … Read more
About This Calculator The Irinotecan Dose Calculator is a clinical support tool designed to help healthcare professionals determine patient-specific dosing for irinotecan-based chemotherapy regimens. It calculates the Body Surface Area (BSA) using the Mosteller formula and adjusts the final dose based on critical patient factors, including UGT1A1 genotype and serum total bilirubin levels, which are … Read more
